Rhumbline Advisers Charles River Laboratories International, Inc. Transaction History

Rhumbline Advisers

$103 Billion
Q1 2024

A detailed history of Rhumbline Advisers transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 87,041 shares of CRL stock, worth $17.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

87,041

Previous 87,122 0.09%

Holding current value

$17.4 Million

Previous $20.6 Million 14.51%

% of portfolio

0.02%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$203.52 - $273.43 $16,485 - $22,147	-81 Reduced 0.09%	87,041 $23.6 Million
Q4 2023 Feb 08, 2024	BUY	$164.52 - $238.84 $308,475 - $447,825	1,875 Added 2.2%	87,122 $20.6 Million
Q3 2023 Nov 09, 2023	SELL	$194.44 - $217.61 $25,860 - $28,942	-133 Reduced 0.16%	85,247 $16.7 Million
Q2 2023 Aug 08, 2023	SELL	$183.71 - $210.25 $1.38 Million - $1.57 Million	-7,489 Reduced 8.06%	85,380 $18 Million
Q1 2023 May 11, 2023	BUY	$191.89 - $259.92 $1.31 Million - $1.78 Million	6,833 Added 7.94%	92,869 $18.7 Million

Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $535,153 - $678,940	2,715 Added 3.26%	86,036 $18.7 Million
Q3 2022 Nov 10, 2022	BUY	$182.44 - $250.54 $113,842 - $156,336	624 Added 0.75%	83,321 $16.4 Million
Q2 2022 Aug 11, 2022	BUY	$204.13 - $302.4 $1.88 Million - $2.79 Million	9,214 Added 12.54%	82,697 $17.7 Million
Q1 2022 May 12, 2022	SELL	$255.51 - $362.11 $3.09 Million - $4.38 Million	-12,085 Reduced 14.12%	73,483 $20.9 Million
Q4 2021 Feb 10, 2022	BUY	$351.38 - $448.68 $1.52 Million - $1.95 Million	4,337 Added 5.34%	85,568 $32.2 Million
Q3 2021 Nov 12, 2021	SELL	$372.64 - $458.3 $1.29 Million - $1.59 Million	-3,468 Reduced 4.09%	81,231 $33.5 Million
Q2 2021 Aug 05, 2021	SELL	$294.17 - $371.65 $14.8 Million - $18.7 Million	-50,319 Reduced 37.27%	84,699 $31.3 Million
Q1 2021 May 06, 2021	SELL	$249.67 - $299.48 $709,811 - $851,421	-2,843 Reduced 2.06%	135,018 $39.1 Million
Q4 2020 Feb 10, 2021	SELL	$222.0 - $252.62 $927,738 - $1.06 Million	-4,179 Reduced 2.94%	137,861 $34.4 Million
Q3 2020 Nov 12, 2020	SELL	$175.56 - $226.45 $902,027 - $1.16 Million	-5,138 Reduced 3.49%	142,040 $32.2 Million
Q2 2020 Aug 13, 2020	BUY	$118.84 - $189.72 $1.48 Million - $2.36 Million	12,432 Added 9.23%	147,178 $25.7 Million
Q1 2020 May 06, 2020	SELL	$98.9 - $178.34 $322,512 - $581,566	-3,261 Reduced 2.36%	134,746 $17 Million
Q4 2019 Feb 05, 2020	BUY	$126.05 - $152.76 $391,259 - $474,167	3,104 Added 2.3%	138,007 $21.1 Million
Q3 2019 Oct 23, 2019	SELL	$125.07 - $143.67 $185,854 - $213,493	-1,486 Reduced 1.09%	134,903 $17.9 Million
Q2 2019 Aug 14, 2019	BUY	$123.4 - $148.55 $180,781 - $217,625	1,465 Added 1.09%	136,389 $19.4 Million
Q1 2019 May 01, 2019	SELL	$104.82 - $146.73 $188,151 - $263,380	-1,795 Reduced 1.31%	134,924 $19.6 Million
Q4 2018 Jan 31, 2019	BUY	$105.09 - $137.23 $3.5 Million - $4.57 Million	33,334 Added 32.24%	136,719 $15.5 Million
Q3 2018 Nov 07, 2018	SELL	$112.11 - $134.54 $401,129 - $481,384	-3,578 Reduced 3.35%	103,385 $13.9 Million
Q2 2018 Aug 06, 2018	BUY	$102.37 - $117.25 $495,675 - $567,724	4,842 Added 4.74%	106,963 $12 Million
Q1 2018 May 02, 2018	SELL	$98.19 - $115.2 $578,535 - $678,758	-5,892 Reduced 5.45%	102,121 $10.9 Million
Q4 2017 Feb 09, 2018	BUY	$100.43 - $118.09 $321,476 - $378,006	3,201 Added 3.05%	108,013 $11.8 Million
Q3 2017 Nov 06, 2017	BUY	$96.72 - $109.26 $10.1 Million - $11.5 Million	104,812	104,812 $11.3 Million

Others Institutions Holding CRL

# of Institutions

728

Shares Held

51.3M

Call Options Held

183K

Put Options Held

346K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.2B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Charles River Laboratories International, Inc. Transaction History